Plaque analysis is now formally recognised, widely accepted, and reimbursable by insurers in the US, including Medicare.

"Now we can actually focus and look at the disease itself, treat the heart disease itself, which is the plaque in the coronary arteries, as opposed to treating the risk of disease," Amir Ahmadi, MD, ...